Q4 2022 13F Holders as of 31 Dec 2022
-
Type / Class
-
Debt / NOTE 4.000%11/1
-
Number of holders
-
20
-
Total 13F principal, excl. options
-
235,496,164
-
Principal change
-
+7,972,400
-
Total reported value, excl. options
-
$132,860,346
-
Value change
-
+$4,389,560
-
Number of buys
-
4
-
Number of sells
-
4
-
Price
-
$0.5496
Institutional Holders of ESPERION THERAPEUTICS INC NE - NOTE 4.000%11/1 as of Q4 2022
21 filings reported holding 29664WAB1 - ESPERION THERAPEUTICS INC NE - NOTE 4.000%11/1 as of 31 Dec 2022.
ESPERION THERAPEUTICS INC NE - NOTE 4.000%11/1 had 20 institutional bondholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of $235,496,164 principal (par value or face value) of the bond of the company.
Largest 10 bondholders included Pentwater Capital Management LP, HIGHBRIDGE CAPITAL MANAGEMENT LLC, Davidson Kempner Capital Management LP, PenderFund Capital Management Ltd., TENOR CAPITAL MANAGEMENT Co., L.P., WHITEBOX ADVISORS LLC, AMERIPRISE FINANCIAL INC, LAZARD ASSET MANAGEMENT LLC, AGF MANAGEMENT LTD, and Point72 Asset Management, L.P..
This table shows the top 20 Bond principal holders of the security as of 31 Dec 2022.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Principal |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.